Iteration 1
Project Iteration 1
Design
We surveyed literature on genes involved in the pathogenicity and survival of Phytophthora spp. and shortlisted targets with roles in virulence and signaling. Since several genes were initially annotated only in related Phytophthora species, their orthologous sequences were retrieved, and a BLAST search was conducted against the P. capsici genome to confirm the presence of homologs. However, preliminary testing revealed high conservation and extensive off-target risks, making many of these targets unsuitable. To refine our approach, we used the transcriptomic data of P. capsici to validate gene expression during infection, which led us to bZIP, a transcription factor critical for pathogenicity.
Build
The complete mRNA transcript was retrieved from curated databases, and siRNA candidates were generated using siDirect and siRNAPred. These were then filtered using established design rules such as URA criteria, GC content distribution, and nucleotide preferences at key positions.
The shortlisted siRNA candidates underwent rigorous structural validation to ensure functional stability and specificity. Target mRNA secondary structures were predicted using RNAfold to confirm binding accessibility, while DuplexFold and MaxExpect evaluated duplex stability and removed unstable constructs. To further strengthen our process, off-target risks were assessed through BLAST searches against the NCBI RefSeq RNA, RefSeq Select RNA, and CORE nucleotide databases. Sequences showing significant similarity to humans, black pepper (P. nigrum), or other local crops were excluded. After two full Design–Build–Test–Learn iterations, four siRNA candidates were finalized as stable, target-specific, and URA-compliant.
Building on these computationally validated candidates, experimentation was designed through iHP, and literature reviews were conducted for potential experiments to gauge the bZIP’s pathogenicity, efficacy, and delivery strategies. The chitosan nanoparticles were synthesized and optimized in the lab for our application. The siRNA was then encapsulated in the nanoparticle to function as the implementable nanoformulation.
Test
Characterization of every nanoparticle and nanoformulation was done using the Particle Size Analyzer. Encapsulation was validated visually using gel retardation assays, and entrapment efficiencies were calculated. A cytotoxicity assay was performed using naked siRNA (ranging from 1.5 nM to 100 μM) on Piper nigrum leaves.
Fluorescence microscopy helped visualize the uptake and internalization of the siRNA, thereby helping us test the release mechanism of the nanoparticle. Detached Leaf Assays were performed both prophylactically and therapeutically, with various controls, to observe the direct effect of the nanoformulation, naked siRNA, and chitosan nanoparticles on the leaves.
Learn
The development of the nanoformulation was optimized through several runs. However, complete encapsulation of the siRNA was not observed, attributed to pH, fluctuation in flow rate, and stirring speed. The siRNA showed 0% cytotoxicity towards the plant at all concentrations. The detached leaf assays directly showed a reduction in lesion formation on application of the solution. This helped us measure the efficacy of our solution. Complimenting these were the motility of the zoospores, which were observed to be less upon the application of our solution. The siRNA design process was lengthy and iterative, prompting us to develop a pipeline integrating sequence retrieval, candidate generation, URA (unique read alignments) based filtering, and structural validation.